title: Anything to declare? Possible risks for patients' health resulting from undeclared plants in herbal supplements.
authors: Eugenia
authors: E
authors: Gallo
authors: Elisa
authors: E
authors: Giocaliere
authors: Silvia
authors: S
authors: Benemei
authors: Anna Rita
authors: AR
authors: Bilia
authors: Anastasia
authors: A
authors: Karioti
authors: Alessandra
authors: A
authors: Pugi
authors: Marina
authors: M
authors: di Pirro
authors: Francesca
authors: F
authors: Menniti-Ippolito
authors: Giuseppe
authors: G
authors: Pieraccini
authors: Luigi
authors: L
authors: Gori
authors: Alessandro
authors: A
authors: Mugelli
authors: Fabio
authors: F
authors: Firenzuoli
authors: Alfredo
authors: A
authors: Vannacci
mesh_terms: D000404:Ajmaline / Q000009:adverse effects; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects*; D001919:Bradycardia / Q000139:chemically induced*; D019587:Dietary Supplements / Q000009:adverse effects; D004340:Drug Contamination; D005260:Female; D041743:Herb-Drug Interactions; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007022:Hypotension / Q000139:chemically induced*; D008517:Phytotherapy / Q000009:adverse effects*; D010936:Plant Extracts / Q000009:adverse effects*; D028321:Plant Preparations / Q000009:adverse effects; D012110:Reserpine / Q000009:adverse effects
chemical_list: D000889:Anti-Arrhythmia Agents; D000959:Antihypertensive Agents; D010936:Plant Extracts; D028321:Plant Preparations; D000404:Ajmaline; D012110:Reserpine